Health Imaging | Homepage

Lantheus to acquire PET agent developer Life Molecular Imaging for up to $750M

LMI is the maker of Neuraceq, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s

Telix Pharmaceuticals to acquire portfolio of imaging-related assets for up to $185M

Inglewood, California-based biotechnology company ImaginAb is the seller, unloading a pipeline of drug candidates, technology platform and research facility.

FDA has approved over 1,000 clinical AI applications, with most aimed at radiology

Diagnostic imaging leads the way in AI product approvals by a mile, accounting for more than 70% of all applications on the list.

Altered brain structure may play a role in eating disorders, MRI data suggest

Experts recently uncovered evidence suggesting behaviors such as undereating, binging and purging could be owed to anatomical alterations in parts of the brain.

Medicare money payment reimbursement dollar decline george washington

Practice managers demand ‘immediate action’ on physician Medicare pay cut

The Medical Group Management Association made its demands in a letter to newly appointed leaders in the U.S. House and Senate sent Tuesday.

Interventional radiologists across the globe agree: Specialty must increase awareness

Researchers recently fielded the survey, hoping to collect information about the state of IR practice and factors that impact access.

Innovation at work

Radiology Business

Bayer: Helping Customers Sustain Patient Care Amid Market Disruptions

As radiology departments across the US continue to navigate the complexities of the current imaging market, including disruptions in supply chains and increased demand for CT contrast media, one constant remains: the need for reliable, quality supply partners to help sustain patient care.

Around the web

Cardiovascular Business

AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.